Annaïs 30 Ceres Pharma

Annaïs 30 by Ceres Pharma contains Drospirenone and Ethinylestradiol, a combination oral contraceptive for pregnancy prevention. This medication is designed for oral use and is manufactured in the EU.

Annaïs 30 is primarily used for contraception, helping to prevent pregnancy by combining two hormones: Drospirenone and Ethinylestradiol. This combination works by preventing ovulation and altering the cervical mucus to hinder sperm movement. It is commonly prescribed for women seeking reliable birth control options.

Common effects of Annaïs 30 may include changes in menstrual bleeding patterns, such as lighter or shorter periods. Some users might experience mild side effects like nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Annaïs 30 should be used under medical supervision. It is important to discuss any pre-existing conditions, such as high blood pressure or a history of blood clots, with a healthcare provider before starting this medication. Regular follow-ups are recommended to monitor for any adverse effects.

Annaïs 30 may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and antifungal drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.